Hoshi Iryo-Sanki Co (TSE:7634) Research & Development: 円0 Mil (TTM As of Mar. 2026)


TSE:7634 Hoshi Iryo-Sanki Co Ltd TSE:7634
85 GF Score
Price 円4,900.00
GF Value 円4,733.91
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Hoshi Iryo-Sanki Co Research & Development?

Hoshi Iryo-Sanki Co TSE:7634 85 Research & Development is 円0 Mil as of Mar. 2026. GuruFocus rates TSE:7634 with a GF Score™ of 85/100 and a GF Value™ of 円4,733.91 (Fairly Valued). The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Hoshi Iryo-Sanki Co's Research & Development for the six months ended in Mar. 2026 was 円0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was 円0 Mil.

Hoshi Iryo-Sanki Co  (TSE:7634) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Hoshi Iryo-Sanki Co Research & Development Related Terms

Hoshi Iryo-Sanki Co Research & Development Historical Data

* Premium members only.

The historical data trend for Hoshi Iryo-Sanki Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hoshi Iryo-Sanki Co Research & Development Chart

Hoshi Iryo-Sanki Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Hoshi Iryo-Sanki Co Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:7634
85GF Score
Hoshi Iryo-Sanki Co Ltd TSE:7634
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hoshi Iryo-Sanki Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of 円0 Mil mean?
Hoshi Iryo-Sanki Co (TSE:7634) has a Research & Development of 円0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Hoshi Iryo-Sanki Co and its competitors.
Is Hoshi Iryo-Sanki Co's Research & Development too high?
Hoshi Iryo-Sanki Co's current Research & Development is 円0 Mil. Overall, Hoshi Iryo-Sanki Co has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Hoshi Iryo-Sanki Co's Research & Development compare to MCK and CAH?
Hoshi Iryo-Sanki Co's Research & Development of 円0 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Distribution company?
A good Research & Development depends on the Medical Distribution industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Hoshi Iryo-Sanki Co and its competitors. Hoshi Iryo-Sanki Co's current Research & Development is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hoshi Iryo-Sanki Co stock overvalued right now?
Based on GuruFocus' analysis, Hoshi Iryo-Sanki Co (TSE:7634) is currently considered Fairly Valued. The stock's GF Value™ is 円4,733.91, compared to a current price of 円4,900.00 — trading 3.5% above its estimated fair value. The current Research & Development is 円0 Mil. Hoshi Iryo-Sanki Co's overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Hoshi Iryo-Sanki Co (TSE:7634), the current Research & Development is 円0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hoshi Iryo-Sanki Co (TSE:7634) Overvalued in 2026?

Based on GuruFocus' analysis, Hoshi Iryo-Sanki Co stock appears to be overvalued. The current stock price of 円4,900.00 is trading 3.5% above its estimated GF Value™ of 円4,733.91. GuruFocus considers Hoshi Iryo-Sanki Co to be Fairly Valued.

Key valuation signals for TSE:7634:

  • Research & Development: 円0 Mil
  • GF Value™: 円4,733.91 vs. price of 円4,900.00 (3.5% above fair value)
  • GF Score™: 85/100 with 2 warning signs

No single metric tells the full story. See the TSE:7634 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hoshi Iryo-Sanki Co Business Description

Address 7-11-18 Iriya, Adachi-ku, Tokyo, JPN, 121-0836
Hoshi Iryo-Sanki Co Ltd is engaged in the manufacturing and sale of pharmaceutical products. The company offers medical oxygen, nitrous oxide, and others. It is also engaged in the planning, manufacture, sale, maintenance, inspection, and repair of medical instrument equipment for medical gas supply facilities. The company's project service includes the production and supply of medical gas, home care, medical gas maintenance, and others.
85GF Score

Get the complete analysis for TSE:7634

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円4,900.00
Price
円4,733.91
GF Value